Multimodality therapy in the management of angiosarcoma of the breast
- 15 November 1982
- Vol. 50 (10) , 2000-2003
- https://doi.org/10.1002/1097-0142(19821115)50:10<2000::aid-cncr2820501004>3.0.co;2-u
Abstract
Five patients with angiosarcoma of the breast were treated with surgery, radiotherapy and an adjuvant Adriamycin containing regimen. Two patients remain disease‐free at 38+ and 20+ months. The median survival of previously reported cases is 22 months with only five patients disease‐free at five years. Possible hormonal influences in the etiologic cause of angiosarcoma of the breast are discussed and the importance of early diagnosis and treatment in these relatively young patients is emphasized.This publication has 5 references indexed in Scilit:
- Angiosarcoma of the breastCancer, 1980
- Feasibility of combined modality therapy for localized high-grade soft tissue sarcomas in adultsInternational Journal of Radiation Oncology*Biology*Physics, 1979
- A clinical and pathological staging system for soft tissue sarcomasCancer, 1977
- Angiosarcoma of the BreastTumori Journal, 1977
- Angiosarcoma of the breastCancer, 1969